Genthod, Switzerland

Jon Lacy

This inventor holds 2 USPTO granted patents. Top assignee: R.p.scherer Technologies, Inc.. Active years: 2004-2006.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 126(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jon Lacy in Pharmaceutical Composition

Introduction: Jon Lacy is a notable inventor based in Genthod, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of fast-dispersing dosage forms for opioid agonists. His work aims to improve the administration and effectiveness of pain management medications.

Latest Patents: Jon Lacy holds two patents related to his innovative pharmaceutical compositions. His latest patent focuses on an opioid agonist in a fast-dispersing dosage form. This invention involves a pharmaceutical composition for oral administration that includes a carrier and an active ingredient, such as fentanyl or a salt thereof. The composition is designed to release the active ingredient rapidly in the oral cavity, making it suitable for various medical applications, including analgesic use, treatment of chronic pain, anesthetic premedication, and management of anxiety.

Career Highlights: Jon Lacy has established himself as a key figure in the pharmaceutical industry through his innovative work. His patents reflect a deep understanding of drug formulation and the needs of patients requiring effective pain management solutions. His contributions have the potential to enhance the quality of life for individuals suffering from chronic pain and anxiety.

Collaborations: Jon Lacy collaborates with Edward Stewart Johnson, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and advancing pharmaceutical research.

Conclusion: Jon Lacy's work in developing fast-dispersing dosage forms for opioid agonists represents a significant advancement in pharmaceutical technology. His patents and collaborations highlight his commitment to improving patient care through innovative solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…